Prostate cancer is treated in a number of different ways, depending on a host of different factors, ranging from the severity of the cancer, the health of the patient, their age, and their own personal choice of treatment. Whether the choice is open or laparoscopic surgery, laser treatment or cryoablation, ultimately, the options open to the urologic surgeon today are modelled and defined specific to the patient's individual needs.
Treatment Methods for Early and Advanced Prostate Cancer focusses on the "how to treat" scenario faced by urologic surgeons treating all stages of prostate cancer by examining all the methods used to treat the condition.
Specifically targeting the fully qualified urologic surgeon, but also highly useful for residents and trainee surgeons wishing to learn and improve their treatment techniques, Treatment Methods for Early and Advanced Prostate Cancer is undoubtedly an extremely popular tool indeed.
Section A: General Considerations Affecting Treatment Options for Patients with Prostate Cancer 1. Mortality trends in prostate cancer, Peter Albertsen 2. Decision-making for men with prostate cancer, Mark Feneley, Leslie Moffat, Charlotte Rees 3. Practical and realistic lifestyle changes and supplements for the man concerned about prostate cancer: what do I tell my patients, Mark Moyad 4. Preservation of sexual function in prostate cancer treatment, James A Eastham 5. Quality of life instruments for prostate cancer, David Penson Section B: Treatment Options for localised prostate cancer 6. Comparison of treatment modalities for prostate cancer by quality of life instruments, David Miller, John Wei 7. Natural history and expectant management of prostate cancer, Jonathan Osborn, Gerald Chodak 8. Clinical trials comparing expectant management to definitive treatment of prostate cancer (PIVOT, Holmberg, PROTECT, etc.), Christopher Parker 9. Anatomical considerations of radical prosptatectomy, Robert Myers, Arnauld Villers 10. Anatomic radical retropubic prostatectomy, J. Kellog Parsons, Alan W. Partin, P Walsh 11. Radical retropubic prostatectomy: contemporary modifications, Murugesan Manoharan, Mark Soloway 12. The role of lymphadenectomy in prostate cancer, Fiona Burkhard, Urs Studer 13. Clinical management of rising prostate specific antigen after radical retropubic prostatectomy, J. Kellogg Parsons, Alan Partin 14. Radical perineal prostatectomy, David M. Hartke, Martin I. Resnick 15. Laparoscopic and robotic radical prostatectomy, Xavier Cathelineau, Carlos Arroyo, Marc Galiano, Francois Rozet, Eric Barret, Guy Vallancien 16. Vattikuti Institute Prostatectomy, James A. Brown, Ashok K. Hemal, Mani Menon 17. Making the transition from open to roboticlly assisted radical prostatectomy, Roger Kirby, Krishna Patil, Chris Anderson, Prokar Dasgupta 18. Initial management of high risk early stage prostate cancer: surgery, Laurence Klotz 19. Prevention And Management Of Complications Associated With Open Radical Retropubic Prostatectomy, Herbert Lepor 20. External beam radiotherapy for the treatment of prostate cancer, David Dearnaley, Vincent Khoo 21. Brachytherapy for the treatment of prostate cancer, Jamie A Cesaretti, Nelson Neal Stone, Johnny Kao, Richard G Stock 22. High dose rate as monotherapy or as a boost: the new prostate brachytherapy, Alvaro A. Martinez 23. Magnetic resonance image-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate, Michele Albert, Mark Hurwitz, Clair Beard, Clare M. Tempany, Robert A. Cormack, Anthony V D’Amico 24. Hyperthermia for treatment of localized prostate cancer, Serdar Deger 25. Initial management of high risk early stage prostate cancer: radiation, Eric Horwitz, Steven J Feigenberg, Alan Pollack 26. Management of biochemical recurrence following radiation therapy, Timothy S Collins, Daniel George 27. Cryotherapy as primary therapy for localised prostate cancer, Ullrich Witzsch 28. Cryotherapy as salvage therapy for prostate cancer, Louis Pisters, Dan Leibovici 29. Neoadjuvant and adjuvant hormonal therapies for prostate cancer: data review and patient perspectives, William A See 30. The assessment and management of urinary incontinence in patients with prostate cancer, J Darwoodi, Z S Dovey, R A Kirby 31. Rehabilitation of sexual function following definitive treatment of local prostate cancer, Francesco Montorsi 32. The limitations of evidence based comparisons of treatment for localized prostate cancer, Lars Ellison 33. Choosing prostate cancer treatment: The clinician as patient, Paul Lange, Paul Schellhammer 34. Coping with a diagnosis of prostate cancer: A patient’s perspective, Brian Wells Section C: Treatment of Locally Advanced and Metastatic Prostate Cancer 35. Androgen deprivation for the treatment of prostate cancer: General principles, David McLeod 36. Hormone therapy for prostate cancer: Optimization and timing, David Kirk 37. Controversies in hormone treatment for prostate cancer, Mario Eisenberger 38. Androgen deprivation for prostate cancer: Future directions, Marc Garnick 39. Intermittent hormone therapy for prostate cancer, Martin Gleave, S Larry Goldenberg 40. Anti-androgen withdrawal syndrome: Identification and treatment, Kathleen W Beekman, Grant Buchanan, Wayne D Tilley, Howard Scher 41. Chemotherapy for advanced prostate cancer Andrew J. Armstrong, Michael Carducci 42. Radiotherapy for the treatment of locally advanced and metastatic prostate cancer, Danny Song, Ted DeWeese 43. Use of bisphosphonates in the management of osseous metastases, Roger Kirby, Jonathan Coxon 44. Management of complications of advanced prostate cancer, Roger Kirby 45. Principles of palliative care and psychosocial support of the metastatic prostate cancer patient, Donald Newling 46. Future directions for treatment of advanced prostate cancer: Gene therapy and other novel modalities, Vasily J Assikis, William Jonas, Jonathan Simons 47. The increasing role of the primary care professional in the care of the prostate cancer patient Michael Kirby